OVXA — Ovoca Bio Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- €0.78m
- -€1.62m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.67 | -1.98 | -2.37 | -5.47 | -5.61 |
Depreciation | |||||
Non-Cash Items | 0.006 | -0.381 | -0.228 | -0.092 | 0.336 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.202 | 0.115 | 0.418 | 1.11 | -0.419 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -2.84 | -2.17 | -2.11 | -4.38 | -5.16 |
Capital Expenditures | — | — | -0.01 | -0.014 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2.03 | 11.1 | 7.59 | -0.053 | 1.51 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.03 | 11.1 | 7.58 | -0.067 | 1.51 |
Financing Cash Flow Items | -0.006 | 0 | -4.09 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.983 | -0.994 | -4.09 | 0 | 0.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.7 | 8.34 | 0.733 | -4.15 | -2.89 |